throbber

`
`
`ÿ
`
` ÿ

` 
`
`8[oz‘gz[udv1101san3Aqfile‘IounquItf‘AAAAAA/fidnqwonpopcorumoq
`
`
`
`  

`
`ÿ ÿ ÿ ÿ
`
`
ÿ
`ÿ
`
`
`
`0022-] 1'67367fl 368-271 ISOZDOIO
`Tue JOURNAL or Imuuuomcv
`Copyrlghl Gil [987 by The American Assoclatlon of Immunologists
`
`Vol. 138. 2711—2717. No. 3. Apr" 15. 1937
`Printed in 0.3.21.
`
`CYTOSTATIC AND CYTOTOXIC ACTIVITY OF TUMOR NECROSIS FACTOR ON
`HUMAN CANCER CELLS1
`
`VITO RUGGIERO.2 KATHRYN LATHAM, AND CORRADO BAGLIONI
`
`From the Department of Biological Sciences. State University of New York at Albany. Albany. NY 12222
`
`The cytostatic and cytotoxic activity of human
`recombinant tumor necrosis factor [rTNF‘] was as-
`sayed on different tumor cell lines. Human BT-2O
`breast and ME-lBO cervix cancer cells were growth-
`inhibited by rTNF. whereas two other cell lines were
`not significantly inhibited. However. when protein
`synthesis was inhibited by cycloheximide. rTNF was
`cytotOxic for these cells but not for BT-20 cells. This
`finding suggested that different mechanisms are
`reSponsible for the cytostatic and cytotoxic activity
`of rTNF. The sensitivity of different cell lines to
`rTNF could not be correlated with a high number or
`affinity of rTNF receptors. Occupancy of only a few
`receptors was sufficient for rTNA cytotoxicity. but
`an increase in receptor number after treatment with
`interferon-7. or a decrease after pretreatment with
`cycloheximide. correspondingly enhanced or de-
`pressed the cytotoxicity of rTNF. It seemed possible
`that some cells could be protected from this effect
`of rTNF by synthesizing “protective” proteins. While
`searching for such proteins. we observed that rTNF
`induced the synthesis of two polypeptides in SK-
`MEL-IOQ melanoma cells. but not in other cancer
`cells. Actinomycin D added with rTNF abolished
`synthesis of these polypeptides. suggesting that
`rTNF induced transcription of the correSponding
`mRNAs. Surprisingly. rTNF stimulated growth of
`SK-MEL-IOQ cells cultured in medium with low se-
`rum.
`
`mediator of cachexla in chronically Infected animals. and
`was designated cachectin (2] before discovering that its
`amino acid sequence is Identical to that of TNF [8. 9].
`TNF shows diverse biological cffects on different cells.
`For example. TNF‘ suppresses lipoprotein lipase activity
`(10]. enhances prostaglandln E2 and collagenase produc-
`tion by human synovial cells and dermal fibroblasts [l l).
`and stimulates bone resorption by osteoclasts [12) and
`production of a procoagulant activity by vascular endo-
`thelial cells (13]. Furthermore. TNF is a mediator of the
`cytocidal activlty of natural cytotoxic cells [14}. These
`activities of TNF follow its binding to high affinity recep-
`tors. which were initially identified in murlne cells (7].
`TNF receptors with a K0 of about 2 X 10"” M have been
`detected in human fibroblasts and tumor cells [15-19].
`It was reported that TNF‘ is cytotoxic for some human
`tumor cell lines and cytostatic for other cells. but that it
`shows no activity on several tumor cells [20. 21). There
`is at present no explanation for this diverse response to
`TNF‘. The present study was aimed at an understanding
`of the different activities of TNF on human tumor cells.
`
`For this purpose. cell lines with a wide range of sensitivity
`to the cytostatic action of TNF were studied. Further—
`more. we examined the activity of TNF‘ on these cells
`treated with cycloheximide [CHX]. because TNF cytotox—
`icity is greatly enhanced by inhibitors of protein and RNA
`synthesis (22).
`
`MATERIALS AND METHODS
`
`A protein found in the serum of primed. endotoxin—
`treated animals elicits hemorrhagic necrosis of some mu-
`rine sarcomas (1] and is designated tumor necrosis factor
`[TNF]."' Priming promotes proliferation of macrophages.
`which are stimulated to secrete ’I‘NF by endotoxin lipo-
`polysaccharide [2]. The human TNF secreted by myelo-
`monoeytlc cells has been purified to homogeneity. se-
`quenced. and produced by recombinant DNA technology
`[3-6]. Human recombinant TNF [rTNF] shows the same
`biological activities as natural TNF‘ (3—6]. A factor se-
`creted by macrophages suppresses lipoproteln lipase ac-
`tivity (7]. This factor has been proposed as an endogenous
`
`Received for publication October 28. 1986.
`Accepted for publication January 6. 198?.
`The costs of publication of this article were defrayed in part by the
`payment of page charges. This article must therefore be hereby marked
`advertisement in accordance with 18 U.S.C. Section 1734 solely to Indl—
`catc this fact.
`' Thls Investigation was supported by US Public Health Service Grant
`CA29895. awarded by the National Cancer Institute. DHHS.
`’ Present address: Istituto di Virologla. Universlta' di Roma. Vlale dl
`Porta 'l‘iburtina 23. 00185 Roma. Italy.
`3 Abbreviations used in this paper: TNF. tumor necrosis factor: rTNF.
`recombinant tumor nacrosls factor: CHX. cyclohexlmlde.
`
`Cells. rTNF. and rl’FN-y. Colon adenocarcinoma HT-29 cells were
`cultured as described [23} in Dulbecco's medium wlth 10% fetal calf
`serum {PCS}. A375 melanoma cells were cultured in RPMI 1640
`medium with 5% FCS. Breast tumor BT-20. cervix carcinoma ME-
`180. and other melanoma cell
`lines were cultured in F~12 and
`minimal Eagle's medium (1/1) with 8% FCS. The cells were resus-
`pended from monolayers with phosphate-buffcred saline [PBS] con-
`taining 1 mM EDTA. rTNF was a gift of Dr. T. lehihara of the
`Suntory Institute for Biomedical Research. Osaka. Japan; rlFN—T
`[1.7 x 107 U/mg] was a gift from Biogen (Cambridge. MA].
`Assays for anttproiiferatiue and cytotoxic activity of r‘l‘NF.
`Growth inhibition was measured by seedng 1 to 4 x 10‘ cells/well
`In cluster plates: the cells were stained with crystal violet after 4
`days of trealment [23]. Cytotoxlcity was measured by treatlng 0.8 to
`2 x 105 cells/well for 18 hr with rTNF and 0.1 mg/ml of CHX. The
`monolayers were washed twice with PBS to remove dead cells and
`were stained with crystal violet. This dye was eluted with 3.3% acetic
`acid and the A5“. was measured In a microdensltometer. The assays
`were carried out in quadruplicate and gave a standard error of <5%.
`Ceii labeling and protein analysis. Confluent monolayers were
`incubated for 2 hr with 25 pCi/ml of [asslmethlonlnc in methionine-
`free medium. After this incubation. the cells were washed twice with
`PBS: 0.2 ml of 0.1 mg/ml leupeptin and 4 mM phenylmethylsulfonyl
`fluoride in 10 mM NaCl. 1.5 mM Mg[0Ac]g. and 10 mM Tris-HCI. pH
`7.4. were added for 10 min. The cells were then Iysed by adding
`sodium deoxycholate and Brij—58 to a final concentration of 0.3%.
`The lysates were centrifuged for 10 min at 30.000 x G. and aliquots
`of the supernatants [200.000 cpm) were fractionated by SDSFPAGE
`on 10% gels. The autoradlographs were scanned in an LKB Ultroscan
`2711
`
`|PR2018—00685
`
`Celgene Ex. 2031, Page 1
`
`IPR2018-00685
`Celgene Ex. 2031, Page 1
`
`

`

` ÿ
ÿ
`
` 
`
`  

`
`
`
`
`
`grog‘gz{udVuoisonfiAqfim'rounutuitf'AAAAAA/fiduq[1101}popcorumoq
`
`
`
`ÿ ÿ ÿ
`
ÿÿ
`
`ÿ
`
`
`
`
`2712
`
`ACTIVITIES OF TUMOR NECROSIS FACTOR
`
`laser densitometer with peaks integrator. The absorbancy of pro-
`teins of interest was normalized to a reference band in each track
`of the autoradiographs which was unchanged in intensity after the
`treatment with rTNF.
`
`RESULTS
`
`Cytostatic and cytotoxic activity of TNF on human
`cancer cells. The cytostatic activity of rTNF was assayed
`on cells seeded at low density to allow exponential growth
`for several days. After 4 days of treatment with different
`concentrations of rTNF. HT-29 and SK-MEL-lOQ cells
`
`were slightly growth-inhibited. whereas MEI-180 and BT-
`20 cells were 50% inhibited by «500 and ~20 pM rTNF.
`respectively (Fig. 1]. These cell lines showed a wide spec-
`trum of sensitivity to the cytostatic activity of i’I‘NF. The
`following experiment was aimed at establishing whether
`these cells were sensitive to rTNF cytotoxlcity. Nearly
`confluent cultures were treated for 18 hr with different
`concentrations of rTNF and 0.1 rug/m1 of CHX. which
`enhances TNF cytotoxicity (22). All of the cell lines were
`extremely sensitive to this treatment. with the exception
`of BT—20 (Fig. 2]. The LD50 was between 0.1 nM rTNF for
`FIT-29 cells and ~50 fM rTNF for ME-180 cells. The
`
`latter cells were sensitive in the cytotoxicity assay to
`rTNF concentrations 10‘-fold lower than those inhibitory
`in the cytostatic assay. However. BT-20 cells were resist-
`ant to cytotoxicity and. conversely. SK-MEL-lOQ cells
`were highly sensitive to rTNF cytotoxlcity but fairly re-
`sistant to its cytostatic activity. This finding suggested
`that some cells could only respond either to the cytostatic
`
`88g
`Agut'ltctconlroll Ao
`
`m0
`
`-
`l.__ ._I_
`
`1
`0.00i
`0.0I
`{1|
`nM rTNF
`
`Figure 1. Dose dependency of the antlprollferstive activity of rTNF on
`four human tumor cell lines. The cells were seeded in wells of cluster
`plates and were treated for 4 days with the rTNF concentration indicated
`in the abscissa. Growth inhibition was measured as indicated in More-
`rlals and Methods; the Aug relative to control untreated cells is shown.
`
`
`s9
`
`It- MEL - P09
`
`E-rao
`"""--..._E‘____.
`
`IOOD
`It)
`POO
`pM rTNF
`
`.l
`
`I
`
`Figure 2. DOSE dependency of the cytotoxic activity of i’I‘NF‘ on four
`human tumor cell lines. The cells were seeded in cluster plates and were
`treated for 18 hr with 0.1 mgfml of CHX and the rTNF concentration
`indicated in the abscissa. The A5“ relative to cells treated with CHX alone
`IS shoWn.
`
`or to the cytotoxic activity of r’I‘NF‘.
`The onset of cell death after treatment with rTNF and
`
`CHX varied among the cell lines examined (Fig. 3]. Cyto-
`toxicity was assayed either after an initial treatment and
`incubation in fresh medium or after continuous incuba-
`tion with rTNF and CHX. In this way. we determined the
`duration of a treatment which caused irreversible dam-
`age and the onset of cell death. A lS—hr treatment was
`required to observe maximal cytotoxicity in HT-29 cells.
`which were insensitive to the cytostatic activity of rTNF.
`whereas 8 hr were required for highly sensitive NIB-180
`cells (Fig. 3]. The onset of cell death after continuous
`treatment with rTNF and Ci-IX was about 8 hr for SK-
`
`MEL-lOQ cells and 2 hr for MEI-180 cells (Fig. 3]. There-
`fore. each cell line showed a different time course of
`
`cytotoxic response. These experiments were carried out
`with a high concentration of rTNF (14.3 nM). but the
`different sensitivity of the various cell lines was refiected
`by the length of the treatment required for cell killing.
`Role of TNF receptors in cytostatic and cytotoxic
`activities. EST-20 cells were grewth-inhibited by pM con-
`centrations of rTNF, Whereas MIC-180 cells were killed
`by f M concentrations in the presence of CHX (Figs. 1 and
`2]. it was not clear whether the sensitivity to such 10w
`rTNF concentrations Was mediated by its binding to a
`single class of receptors. it was reported previously that
`HT~29 and SK—MEL- 109 cells have, respectively. 800 and
`9000 receptors per cell (23] and MEI-180 cells have 2000
`receptors per cell (19). The [to of these receptors is ~2 x
`10“0 M (19. 23]. We measured the binding of ”Ed-rTNF
`to BT-2O cells at 4°C. as described (23). and found 900
`receptors per cell with a KB of about 1 X 10—10 M. There-
`fore. the sensitivity of these cells to the activity of r’l‘NF
`cannot be explained by a different number or binding
`affinity of these receptors.
`A 50% occupancy of receptors by 0.2 nM rTNF (on the
`
`
`
`4
`
`3
`
`12
`
`I5
`
`Figure 3. Time course of cytotoxicity in cells treated with 0.] rug/ml
`of CHX and 14.3 nM rTNF. The cells were either continuously treated [I]
`and stained with crystal violet at the time indicated in the abscissa. or
`were treated for the time indicated in the abscissa. were washed four
`times. were incubated with fresh medium up to 20 hr. and were then
`stained [l]. The Am relative to Cultures treated with CHX alone is shown.
`
`|PR2018—00685
`
`Celgene Ex. 2031, Page 2
`
`
`
`amisofoooiroll 8
`::\.\...
`
`\ac'
`
`IPR2018-00685
`Celgene Ex. 2031, Page 2
`
`

`

`
`
`
`ÿ
`
` ÿ

` 
`
`
`
`  

`
`ÿ ÿ
`ÿ ÿ
`
`
ÿÿ
`
`SIOZ‘gz{udVuoisonfiAq/310'{0ul1u1u1i_f’AAAAAA//Idllqmm}popeoiumoq
`
`ACTIVITIES 0F TUMOR NECROSIS FACTOR
`
`IOD
`
`,E' 80
`E
`.L 60
`5
`T 40
`if
`as 20
`
`basis of the [(9 measured at 4°C] resulted in maximal
`growth inhibition of BT-20 cells (Fig. 1]. but only very
`few TNF receptors could be occupied by 50 mt rTNF.
`which was cytotoxic for ME-lSO in the presence of CHX
`(Fig. 2}. However. the following experiment showed that
`the relative number of TNF receptors within a cell line
`determined its sensitivity to cytotoxicity. We took advan~
`tage of the observation that the TNF receptors of HT-29
`cells are increased up to threefold by treatment with IFN—
`7. but the Km of these receptors is unchanged (23]. This
`is a specific response to lFN-y. because no increase in
`TNF receptors is detected in PIT-29 cells treated with lFN-
`a2 (23]. Cytotoxicity was measured in HT-29 cells pre-
`treated for 5 hr with lFN-y; these cells were killed by
`rTNF concentrations threefold lower than those required
`to kill control cells (Fig. 4}. This experiment indicated
`that the TNF receptors induced by IFN-v may be involved
`in the cytotoxic response.
`Further evidence that the cytotoxic response was re-
`lated to the number of receptors was obtained by treating
`ME-180 cells with CHX before ‘251-1’I‘NF binding. As
`shown in Figure 5A. inhibition of protein synthesis re-
`sulted in a drastic reduction in TNF binding. Few TNF
`receptors were detected after 2 hr. but the receptors
`reappeared when the inhibition of protein synthesis was
`reversed by incubating the cells in fresh medium (Fig.
`5A]. This indicated that TNF receptors turned over with
`a very short half—life. The rTNF cytotoxicity decreased by
`about 50% when the number of receptors was reduced
`by 90%. and was almost abolished after MEI—130 cells
`were preincubated for 2 hr with CHX (Fig. 53). Therefore.
`the cytotoxic response was inhibited when the rTNF
`receptors decreased below a critical number. This. and
`similar experiments carried out on HeLa S2 cells [data
`not shown]. showed that the rTNF receptors turned over
`with a half-life of ~30 min when protein synthesis was
`inhibited.
`
`Induction of the synthesis of new proteins in TNF-
`treated cells. A possible explanation for the high sensi-
`tivity to rTNF of cells treated with Clix is an inhibition
`of the synthesis of proteins which may be induced by
`rTNF and may protect the cells from cytotoxicity. This
`
`Am(93ofcontrol1
`
`I00
`
`43a)a:OO0
`
`NO
`
`pM
`Figure 4. Effect of pretreatment with iFN-y on rTNF cytotoxicity. HT-
`29 cells [2 x 10") were seeded in each well of a cluster plate and were
`treated for 5 hr with 25 ngfml of lF‘N-‘y {A} or were kept as controls (0].
`The cells were then washed and were incubated for 18 hr with fresh
`medium containing 0.1 mg/mi of CHX and the rTNF concentration indi—
`cated in the abscissa. The A5...) relative to cultures treated with CHX alone
`ls shown.
`
`20
`
`B
`
`100
`
`so ,,
`:5
`so 5
`‘3
`40 u
`a!
`
`Hours
`Figure 5. Bindingof ”"i-fl‘NF {A} and cytotoxicity of rTNF (B) for ME-
`180 cells treated with CHX. A. Confluent ME-lSO monolayers in ENS-cma
`plates {-4.3 x 10“ cells/plate] were incubated with 0.] mg/‘ml cyclohexi-
`mlde for the time indicated in the abscissa. or after 2 hr incubation
`(arrow) the cells were washed and were incubated in fresh medium.
`Binding of 0.15 nM lz’l—r’l‘i'llF‘ was measured after 3 hr at 4°C. Nonspecific
`binding was determined by adding a IOU-fold excess of unlabeled (TNF.
`and was on the average 14% of total binding. Nonspecific binding is
`subtracted from the data shown. The binding is expressed as a percentage
`of that of untreated ME-l 30 cells (1610 cpm]. B. MES-180 cells seeded in
`cluster plates were treated with 0.1 mgfrnl of CHX for the time indicated
`in the abscissa before the addition of i phi 1’1“NF. The cells were incubated
`for a further 18 hr before staining with crystal violet. The percent
`cytotoxicity was calculated from the formula I — all) x 100. where a and
`b are the AW of cells treated with rTNF plus CHX and of cells treated
`with CHX alone.
`
`explanation has been suggested by the observation that
`relatively short incubations with TNF alone protect some
`cells from the cytotoxicity of a subsequent combined
`treatment with TNF and cycloheximide (24]. In the follow-
`ing experiments. we observed that rTNF induced the
`synthesis of two proteins in SK~MEL»109 cells. but we
`could not detect any proteins synthesized in response to
`rTNF in other cell lines. This finding argues against a
`protective role for the TNF-induced proteins.
`SK-MEL—lOQ cells were treated for different times and
`with different concentrations of rTNF and were labeled
`
`with [35$]methionine. The proteins were examined by gel
`electrophoresis and autoradiography (Fig. 6]. The synthe-
`sis of two proteins of Mr 42.000 and 36.000 [p42 and
`p36) was detectable in SK-MEL-lOQ cells labeled from 2
`to 4 hr after the addition of 10 ng/ml rTNF (Fig. 6A] and
`in cells treated for 18 hr with 0.1 ng/ml of rTNF and
`labeled for the last 2 hr (Fig. SB]. Induction of p42 was
`quite evident. because there was little background in the
`corresponding position of the gel track of untreated cells.
`Hawever. p36 was clearly separated from other bands in
`some gels (Fig. 6A]. but was incompletely separated in
`other gels (Fig. SB]. Small changes in the composition or
`time of polymerization of the gels appeared to be respon-
`sible for this variability.
`The autoradiographs of the experiments shawn in Figs
`are 6 and of other similar experiments were scanned in
`a microdensitometer to measure the amount of p42 and
`p36 relative to a reference band (Fig. 7]. The induction of
`p36 and p42 was correlated with the rTNF concentration
`(Fig. 7A]. The time course of induction of p36 showed a
`peak at 3 hr and a decline in the synthesis of this protein
`afterwards. whereas the synthesis of p42 increased with
`the time of rTNF treatment up to 8 hr and then leveled
`off (Fig. 731. Synthesis of these proteins could not be
`detected in the other cell lines examined for sensitivity
`to rTNF (Fig. 6C and data not shown]. It seemed possible
`that this response to TNF could be characteristic of me]-
`anoma cells. Therefore. the proteins synthesized by the
`melanoma cell lines A375. SK-MEL-13 (Fig. BC). SK-
`
`|PR2018—00685
`
`Celgene Ex. 2031, Page 3
`
`IPR2018-00685
`Celgene Ex. 2031, Page 3
`
`

`

`
`
`
`ÿ
`
` ÿ

` 
`
`SIOZ‘gz{advnolsonSAq/810'{oununut_f'AAAAAA//zd11q{1101;popeoiumoq
`
`
`
`  

`
`ÿ ÿ
`ÿ ÿ
`
`
ÿÿ
`
`
`
`2714
`
`ACTIVITIES OF TUMOR NECROSIS FACTOR
`
`l—Hours—1
`M,xlo"0
`4
`6
`8
`l6
`-
`
`r-ng/rnl rTNF—I
`.9".
`I__
`IO
`so
`
`
`':"*3“".3;f:3
`
` .'F‘lIr" ..
`
`
`
`
`HT-29
`
`5.3?5
`
`SK-lB
`~
`+rTNF
`‘
`
`
`
`
`A
`
`Figure 6. Proteins synthesized by SK-MEL-lOQ cells treated for increasing times with It) rig/ml ol' rTNF [A] or treated [or let hr with Increasing
`concentrations of r'i‘NF‘ [BL and by other cell lines [(3) treated for 18 hr with [0 ng/ml of rTNF [+1. or untreated [—|. The cells were labeled with 1"531
`methionine during the final 2 hr of incubation with rTNF. Proteins were separated by clectrophoresison lG‘fE gels and the ailtoratiimzrophs are shown.
`The position of M. markers and of the two proteins induced by rTNF in SK—Ml-Ii.~i09 cells is indicated.
`
`
`
`nM
`
`Hours
`
`Figure 7. Dose response [Al and time course [it] of the induction of
`p36 and p42 by rTNF in SK-MEL-IGQ cells. Autoradiographs like. those
`shown in Figure 5 were scanned in an LKB laser mierodensltometer with
`peak area integrator. The absorbancy of the p36 and 1342 bands normal-
`lzed to that of a protein band which did not change with the rTNF
`treatment is shown in arbitrary units.
`
`MEL-28. and DX-2 (data not shown] were examined be«
`fore and after treatment with rTNF. These cells did not
`
`show induction of p36 and p42. although they were
`sensitive to the cytostatic activity of rTNF [0.6 nM rTNF
`inhibited A375 and SK-MEL-IS cells 50 and 60%. re-
`
`spectively. in the assay described in Fig. 1. whereas it
`inhibited SK-MEL-ZS and DIX-2 cells 30 and 10%. re-
`
`spectively}. Furthermore. HeLa cells. human osteosar-
`coma cells. and lung adenocarcinoma [A549] cells were
`examined before and after treatment with rTNF. but
`
`failed to show induction of p36 and p42 (data not shown).
`The only other cells which synthesize two new proteins
`in response to rTNF. in addition to SK-MEL-IOQ. are
`human fibroblasts (25]. When a sample of labeled protein
`obtained from rTNF-treated fibroblasts was run along-
`side that from SK-MEL-lOQ cells. the proteins induced
`by rTNF co-mlgrated. This showed that rTNF‘ induced
`synthesis of presumably identical proteins in fibroblasts
`and SK-MEL-IOQ cells.
`
`The addition of l pgfml actinomycin D to SK-MEL-IOQ
`cells together with rTNF abolished the induction of p36
`
`and p42. This finding suggested that transcription of the
`mRNA for these proteins was induced by rTNF. An ex-
`periment was performed to establish whether this was a
`primary induction or whether synthesis of other proteins
`was required to induce transcription of p36 and p42
`mRNA. SK-MEL-IOQ cells were treated with rTNF in the
`
`presence of CHX. were washed. and were then labeled
`with l"5S]methionine. Both p36 and p42 were synthesized
`by cells treated in this way [Fig 8]. The synthesis of p36
`appeared to be superinduced. suggesting that the mRNA
`for this protein accumulated when protein synthesis was
`blocked. This finding agreed with the observation that
`maximal synthesis of p36 was an early response to rTNF
`and that its synthesis declined after a few hours [Fig. 7].
`This result suggested that transcription of mRNA for p36
`and p42 was a primary event. which did not require
`ongoing protein synthesis.
`The stability of p42 was examined in an experiment in
`which SK-MEL-lOQ cells labeled during treatment with
`rTNF were washed and were incubated for increasing
`times in fresh medium before SDS-PAGE analysis. The
`p42 band was measured by dcnsitometry of the autora-
`diographs and did not decrease during a 6-hr chase (Fig.
`9]. The decay of the synthesis of p42 on removal of rTNF‘
`was examined by labeling SK-MEL—IOQ cells after incu-
`bation in fresh medium (Fig. 9]. The synthesis of p42
`declined ~50??? in 6 hr. suggesting that p42 mRNA de—
`cayed with a similar half-life when rTNF‘ was removed.
`However. alternative explanations for the decline in p42
`synthesis. such asa translational reguiatory mechanism.
`Cannot be ruled out. Similar studies on the. decay of p36
`synthesis could not be carried out because of the incom-
`plete resolution of this protein from other bands.
`A preliminary characterization of p42 and p36 has
`been carried out. These proteins are not membrane-
`bound. because they can be extracted by homogenizing
`SK-MEL-IOQ cells in low ionic strength buffer without
`added detergents. By labeling rTNF-trcatcd cells with
`inorganic 32P and analyzing phosphopmtcins by gel elec-
`
`|PR2018—00685
`
`Celgene Ex. 2031, Page 4
`
`IPR2018-00685
`Celgene Ex. 2031, Page 4
`
`

`

`
`
`
`ÿ
`
` ÿ

` 
`
`8{oz‘gz{pdVuoisonfiAqfiJO'Iounqunf'AAAAAA/fiduq11101}papeorumoq
`
`
`
`  

`
`ÿ ÿ ÿ ÿ
`
`
ÿ
`ÿ
`
`
`
`ACTIVITIES OF TUMOR NECROSIS FACTOR
`
`2715
`
`
`
`Figure it). Growth-stimulatory activity of rTNF on SK—MEL—IOQ cells.
`Cells. 2 x 10‘. were seeded per well of cluster plates. were incubated
`overnight. were washed three times with medium minus serum. and were
`cultured in medium supplemented either with 0.2% PCS or with 0.5%
`l-‘CS. After 3 days. 0.1 ng/mi of rTNF were added to some wells |+TNFL
`whereas others were kept as controls {C}. On days subsequent to rTNF
`addition. individual wells were stained and the Anna was measured as
`described In Materials and Methods.
`
`shown]. This polypeptide may correspond to p36. but
`further experiments will be required to establish that p36
`is Indeed a phosphoprotein.
`Growth-stimulatory activity of TNF. It was reported
`previously that rTNF‘ can stimulate human fibroblasts to
`divide {21. 26. 27]. Because of the similarity between the
`response of SK—MEL-lOQ cells and fibroblasts to rTNF‘.
`shown by the induction of p36 and p42. we investigated
`whether these melanoma cells were also stimulated to
`
`divide by rTNF. No difference in growth rate was observed
`between control and rTNF-treated cells grown in 7.5%
`serum [data not shown]. However. when the serum con-
`centration was decreased to 0.5 or 0.2%. rTNF stimulated
`
`proliferation of SK—MEL-iOQ cells about 20% (Fig. 10].
`This effect of rTNF on cell growth was not observed in
`experiments with HT-29 cells [data not shown]. These
`findings indicated that rTNF can paradoxically stimulate
`the growth of some cancer cells.
`
`DISCUSSION
`
`Some cancer cells. such as BT-20. are particularly
`sensitive to the cytostatic activity of TNF‘. whereas other
`cells are insensitive. We observed that rTNF‘ is cytotoxic
`for these cells. but not for BT-20 cells. when protein
`synthesis is inhibited. This finding suggests that the
`cytostatic and cytotoxic activities of rTNF‘ may be medi-
`ated by separate mechanisms which are poorly under-
`stood. The rTNF‘ alone does not appear to be significantly
`cytotoxic for the cancer cell lines studied. This result
`differs from a previous report that a partially purified
`TNF produced by LukII lymphoblastoid cells is by itself
`cytotoxic for BT-20 cells [20]. Possible explanations for
`this discrepancy are the presence of other cytotoxins in
`the TNFiLukII} preparation and the different cytotoxicity
`assay used by Williamson et a1. (20).
`The extraordinary sensitivity of MEI-180 cells to the
`cytotoxic effect of TNF‘ in the presence of CI-IX has not.
`to our knowledge. been reported previously. The use of
`ME-IBO cells as a target
`in the TNF bioassay might
`represent a significant methodological advance over the
`commonly used assay with 1.929 cells. The cytostatic or
`cytotoxic response to rTNF cannot be correlated in gen-
`eral with a different number or affinity of cellular recep-
`tors. but a lack of receptors may account for the finding
`that human B lymphoblastoid cell lines are insensitive to
`|PR2018—00685
`
`Celgene Ex. 2031, Page 5
`
`o__b
`
`c
`
`d
`
`Mr I I0"3
`200'-
`
`
`
`-
`
`—
`
`+
`
`+
`
`rTNF
`CHx
`
`Figures. Synthesis of p36 and p42 by SK-MEL-IOQ cells treated with
`rTNF In the presence of CHX. Cells seeded In cluster plates were treated
`for 3 hr with 10 ng/ml of rTNF cur/and with 0.] mgfml of CHX. as Indicated
`tn the figure. The cells were then washed and were. labeled for 2 hr with
`|°5S|methionlne. Proteins were fractionated by gel electrophoresis. and
`the autoradiograph is shown. The position of M. markers of p36 and p42
`ls indicated.
`
` 2
`
`6
`
`4
`Hours
`
`Figure 9. Stability of p42 and decay of Its synthesis in SK-MEL- l 09
`cells after removal of rTNF‘. Cells. 3 X 10‘. were seeded per well of cluster
`plates and were grown overnight: then it) ng/ml of rTNF were added for
`19 hr. The stability of p42 was examined by labeling the cells with la’SI
`methionine during the final 2 hr of rTNF' treatment. washing the cells.
`and adding fresh medium for the time indicated before analyzing cell
`proteins by gel electrophoresis. Automdlographs were scanned in a mi-
`crodensitometcr. and the absorbancy of the p42 band before the chase
`[I] or after the chase [x] is indicated In arbitrary units. The decay of the
`synthesis of p42 was examined by washing the cells after the treatment
`with r'i'NF and lncubatlng the cells In fresh medium. The cells were
`labeled from 0 to 2. 2 to 4. and 4 to 6 hr after r'l‘NF‘ removal [I]. Samples
`were processed and were analyzed as described In Materials and Meth-
`ads.
`
`trophoresis. we could exclude that p42 is phosphorylated.
`A phosphorylated polypeptide corresponding in M, to p36
`increased with the time of rTNF‘ treatment {data not
`
`IPR2018-00685
`Celgene Ex. 2031, Page 5
`
`

`

`
`
`
`ÿ
`
` ÿ

` 
`
`
`
`
`
`  

`
`ÿ ÿ ÿ ÿ
`
`
ÿ
`ÿ
`
`
`
`8[oz‘gz(pdv1101san3Aqfile‘Iounquuf‘AAAAAA/fidnq{110.1}papzoplmoq
`
`2716
`
`ACTIVITIES OF TUMOR NECROSIS FACTOR
`
`rTNF cytOstatic activity (1 7]. Accordingly. a loss of recep-
`tors in CHX—treated ME- 1 80 cells abolishes rTNF cytotox-
`icity. but an increase in receptors in HT-29 cells treated
`with IFN-y enhances rTNF cytotoxicity (Fig. 4]. The rapid
`loss of rTNF receptors in CHX-treated cells (Fig. 5] shows
`that these receptors turn over with a half-life of ~30 min.
`This is a very short half«life for the receptor of a mediator
`of cell growth and differentiation such as TNF. This
`finding may have some implications for the mechanism
`of action of r’I‘NF. In ME-lBO cells treated with CHX and
`
`rTNF. the events which lead to cytotoxicity must take
`place within a relatively short time of the binding of rTNF
`to receptors. At the rTNF concentration causing 50%
`cytotoxicity of MEI-180 cells (~50 fM]. only about one cell
`in two will have a TNF molecule bound at any given time.
`This calculation is based on the Kg value and receptor
`number calculated for TNF binding at 4°C. However.
`receptor occupancy may be initially greater at 37°C. but
`in the presence of CHX the number of receptors drops
`very rapidly. It therefore seems possible that a single “hit"
`may suffice to kill ME-180 cells in a relatively short time.
`Interestingly. a model proposed by Ruff and Gifford (28]
`is based on a less—than—first—order kinetics of the dose
`
`response to the cytocidal activity of TNF. and may explain
`the apparent sensitivity to a single hit of extremely sen-
`sitive cells such as ME-lSO. However. it is now known
`
`why a long treatment with rTNF is required to kill rela-
`tively insensitive cells such as HT—29. Continuous bind-
`ing of rTNF to residual receptors or a slower turnover of
`these receptors may explain this finding.
`A possible explanation for the various activities of TNF
`is a different cell response to signals from TNF-receptor
`complexes. but as yet there is no available information
`on their mechanism of signal transduction. We can gain
`some insight on the events which follow the binding of
`rTNF to receptors by examining the cellular response to
`this factor. The finding that most cells are only sensitive
`to the cytotoxic activity of TNF when protein synthesis
`is inhibited suggests that these cells counteract the activ-
`ity of TNF by synthesizing some hypothetical "protective"
`protein. Failure to synthesize such protein may result in
`irreversible damage to TNF-treated cells. The ability of
`TNF to induce synthesis of new proteins is shown by the
`present finding that SK-MEL-IOQ cells synthesize p36
`and p42 after a few heurs of treatment with rTNF. The
`possible role of these proteins is unknown. but they are
`not synthesized in appreciable amounts by other cancer
`cells sensitive to TNF cytotoxicity. Therefore. it seems
`unlikely that these proteins play some role in counter-
`acting this cytotoxicity and that “new" proteins need to
`be synthesized by TNF-treated cells to block its cytotoxic
`activity. as suggested by the observation that a short
`pretreatment with TNF alone protects some lines after
`the subsequent addition of CHX {24. 25). Furthermore.
`the cell lines examined in the present investigation were
`not protected from cytotoxicity by pretreatment with
`rTNF alone (our unpublished observations].
`Synthesis of p36 and p42 represents a novel biological
`activity of TNF. which can be added to the long list of
`activities elicited by this pleiotropic factor in different
`cells. The synthesis of these polypeptides is not observed
`when fibroblasts are incubated with rTNF in the pres—
`ence of CHX. are washed. and are then labeled (25]. In
`contrast. p36 and p42 are synthesized by SK-MEL-IOQ
`
`cells treated in the same way (Fig. 8]. The synthesis of
`the mRNA for these proteins is a “primary” response in
`SK—MEL- 109 cells. but apparently not in fibroblasts [25].
`However. it seems possible that the same basic regulatory
`mechanism exists in both cell types. but that metabolic
`differences between melanoma cells and fibroblasts re-
`sult in altered stability of the protein intermediates in-
`volved in initiating p36 and p42 synthesis.
`It is surprising that rTNF induces Synthesis of p36 and
`p42 in only one of the melanoma cell lines tested. These
`SK-MEL-lOQ cells respond to rTNF similarly to fibro-
`blasts. and synthesize these proteins at an enhanced rate
`as long as rTNF is present in the culture medium [25}.
`However. we have observed that the synthesis of p42
`decays in SK-MEL-IOQ cells when rTNF is removed. in-
`dicating that the mRNA for this protein turns over with
`a half-life of 6 hr. Surprisingly. in medium with low
`serum. rTNF stimulates the proliferation of SK-MEL- 109
`cells. This observation suggests that TNF has a rather
`unique activity on SK-MEL-IOQ cells and that it can
`promote growth of these cancer cells. A likely explanation
`for these findings is that SK-MEL- 1 09 cells possess so

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket